CONTRACEPTION is a leading academic journal dedicated to advancing the field of reproductive health, published by Elsevier Science Inc. Since its inception in 1970, the journal has consistently provided a platform for high-quality research and insights in both Obstetrics and Gynecology and Reproductive Medicine, achieving notable recognition as a Q1 journal in these categories as of 2023. With an impact factor that underscores its significance—ranked #57 out of 209 in Obstetrics and Gynecology and #28 out of 90 in Reproductive Medicine according to Scopus—CONTRACEPTION is essential reading for researchers, clinicians, and students alike. The journal is committed to publishing innovative studies, review articles, and evidence-based guidelines that inform clinical practice and enhance patient care. Although it does not currently offer open access options, its comprehensive coverage of contemporary issues and empirical data makes it an invaluable resource for those invested in the future of reproductive healthcare.

Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

ACTA Obstetricia et Gynecologica Scandinavica, published by Wiley, is a leading journal in the fields of obstetrics and gynecology, with its impressive history dating back to 1921. This esteemed journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Obstetrics and Gynecology, positioning it in the top percentile of global research outputs according to Scopus. With an exceptionally high percentiles rank, #16 out of 209, it serves as a vital platform for researchers, practitioners, and students eager to contribute to and gain insights from cutting-edge studies impacting women's health. Although it does not currently provide open-access options, the journal’s rigorous peer-review process ensures that high-standard research reaches its diverse audience. By converging years of knowledge towards 2024, ACTA Obstetricia et Gynecologica Scandinavica continues to be essential in discussing contemporary issues and advancements in reproductive health, fostering significant scientific discourse and innovation.

The Australian & New Zealand Journal of Obstetrics & Gynaecology (ISSN: 0004-8666, E-ISSN: 1479-828X), published by Wiley, stands as a premier peer-reviewed journal dedicated to the evolving fields of obstetrics and gynecology. With a rich history spanning from 1961 to 2024, this esteemed journal serves a global audience, primarily in the United States, and plays a pivotal role in disseminating cutting-edge research, clinical trials, and innovative practices within the specialty. As of 2023, it holds a noteworthy Q2 ranking in both the Medicine (miscellaneous) and Obstetrics and Gynecology categories, underscoring its relevance and contribution to medical literature, with an impressive Scopus rank of #87 out of 209, placing it in the 58th percentile of its field. Although it does not offer open access, the journal remains a vital resource for researchers, healthcare professionals, and students seeking to stay abreast of the latest advancements and discussions in women's health. By publishing high-quality research, it not only advances clinical practices but also fosters ongoing education and improvement in care for women across Australia, New Zealand, and beyond.

Gynakologie is a specialized academic journal published by Springer Heidelberg, focusing on the dynamic field of obstetrics and gynecology. With an ISSN of 2731-7102 and an E-ISSN of 2731-7110, the journal aims to provide a platform for innovative research and discussions that contribute significantly to women's health. Launched in 2022 and set to converge by 2024, it has quickly established itself within the academic community, currently ranking in the Q4 category in Obstetrics and Gynecology as per the 2023 quartile assessments. Despite its current positioning, the journal is dedicated to enhancing visibility and scholarly impact in this essential medical field. Published in Germany, it plays an important role in disseminating valuable insights and findings among researchers, clinicians, and students alike, thus fostering a better understanding of women's health issues. While the journal currently lacks open access options, it remains committed to contributing to the body of knowledge and advancing practices that benefit patients worldwide.

The Journal of Gynecology Obstetrics and Human Reproduction, published by Elsevier Masson, is an esteemed platform dedicated to advancing knowledge in the fields of gynecology, obstetrics, and reproductive medicine. Established in 2016, this journal has quickly gained prominence, currently holding a Q2 ranking in both Obstetrics and Gynecology, as well as Reproductive Medicine, as of 2023. With its base in France, the journal aims to provide crucial insights and the latest research findings, catering to a diverse audience of researchers, professionals, and students. The journal operates under the open access model, ensuring that high-quality articles are freely accessible, fostering collaboration and knowledge exchange among practitioners and scholars. With a broad scope covering various facets of women's health, the Journal of Gynecology Obstetrics and Human Reproduction is committed to contributing to the advancement of research and practice in these vital fields.

Welcome to the European Journal of Obstetrics & Gynecology and Reproductive Biology, a premier publication dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier, this journal has been a vital resource since its inception in 1971, continuing to provide high-quality, peer-reviewed research through 2024 and beyond. With an impressive impact factor and recognized in the Q2 quartile for both obstetrics and gynecology, as well as reproductive medicine, it ranks among the top journals in its field, being positioned at #59 out of 209 in Obstetrics and Gynecology and #29 out of 90 in Reproductive Medicine. Though not currently an Open Access journal, it remains committed to disseminating valuable findings to enhance clinical practice and facilitate further research. Researchers, professionals, and students can expect insightful articles, comprehensive reviews, and pioneering studies that significantly impact women's health and reproductive biology.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed academic journal that has been providing critical insights and reviews in the fields of Obstetrics and Gynecology since its inception in 1989. With an ISSN of 1040-872X and an E-ISSN of 1473-656X, this journal plays a vital role in disseminating impactful research findings, clinical practices, and emerging trends in women's health. As a recognized entity in the medical community, it proudly ranks in the second quartile (Q2) across both Medicine (miscellaneous) and Obstetrics and Gynecology categories, underscoring its significance in shaping contemporary discourse. With an impressive Scopus ranking of #69 out of 209 in its field, it reflects a strong commitment to relevance and excellence in research. Although currently not offering open access, it remains a crucial platform for researchers, healthcare professionals, and students seeking to enhance their understanding and practice in obstetrics and gynecology. The journal’s ongoing evolution through to 2024 ensures that it will continue to be at the forefront of scientific advancement and clinical guidelines in women's health.

The International Journal of Women's Health (ISSN: 1179-1411, E-ISSN: 1179-1411) is a premier open-access journal published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the knowledge and practice related to women's health across a spectrum of disciplines. Situated in New Zealand, this journal has rapidly established itself as a significant resource in the field, reflected in its impressive ranking within the Q1 and Q2 categories across maternity and midwifery, obstetrics and gynecology, and oncology, as of 2023. With a Scopus ranking of #6 out of 43 in Nursing – Maternity and Midwifery and #80 out of 209 in Medicine – Obstetrics and Gynecology, the journal highlights the critical importance of women's health issues in both clinical and research settings. Its open-access model ensures that vital research findings are readily available to practitioners and scholars worldwide, making impactful contributions to healthcare practices and policies. Researchers, professionals, and students alike will find the International Journal of Women's Health an essential platform for disseminating innovative research and insights.

Minerva Obstetrics and Gynecology, an esteemed journal published by EDIZIONI MINERVA MEDICA, serves as a vital resource in the field of obstetrics and gynecology. With an ISSN of 2724-606X and an E-ISSN of 2724-6450, this open access journal aims to disseminate high-quality research and clinical studies that address contemporary challenges and advancements in women's health. Since its inception in 2021, Minerva Obstetrics and Gynecology has garnered recognition within the academic community, achieving a commendable Q3 ranking in the 2023 category of Obstetrics and Gynecology, and placing at the 54th percentile among peers in its Scopus rankings. The journal not only facilitates the exchange of innovative ideas but also encourages collaboration among researchers, healthcare professionals, and students from around the globe. With a commitment to excellence, it aims to address significant topics that impact clinical practice, ensuring that practitioners remain informed about the latest evidence-based practices. For researchers and practitioners aiming to contribute to the advancement of gynecological and obstetric medicine, Minerva Obstetrics and Gynecology represents a prominent platform for publication and engagement.